Benjamin Burnett
Stock Analyst at Stifel
(2.02)
# 2,895
Out of 4,734 analysts
66
Total ratings
39.13%
Success rate
-5.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPTX Repare Therapeutics | Maintains: Buy | $9 → $4 | $1.28 | +212.50% | 5 | Dec 13, 2024 | |
| IRON Disc Medicine | Maintains: Buy | $79 → $90 | $58.25 | +54.52% | 6 | Dec 10, 2024 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $66.48 | +83.51% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $23.44 | +194.37% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $22.18 | +206.58% | 7 | Sep 10, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $60 → $59 | $40.53 | +45.57% | 5 | Aug 6, 2024 | |
| PGEN Precigen | Maintains: Buy | $7 → $10 | $1.11 | +800.90% | 3 | Jun 3, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.82 | +152.75% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $6.57 | +775.19% | 4 | Apr 1, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $40.29 | +16.65% | 3 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.91 | +323.01% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5.3 → $5 | $1.27 | +293.70% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $690 → $780 | $4.96 | +15,625.81% | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.89 | +2,590.58% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $1.09 | +1,367.89% | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,880 → $1,400 | $8.35 | +16,666.47% | 3 | Mar 27, 2020 |
Repare Therapeutics
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.28
Upside: +212.50%
Disc Medicine
Dec 10, 2024
Maintains: Buy
Price Target: $79 → $90
Current: $58.25
Upside: +54.52%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $66.48
Upside: +83.51%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $23.44
Upside: +194.37%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $22.18
Upside: +206.58%
CRISPR Therapeutics AG
Aug 6, 2024
Maintains: Hold
Price Target: $60 → $59
Current: $40.53
Upside: +45.57%
Precigen
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.11
Upside: +800.90%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.82
Upside: +152.75%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $6.57
Upside: +775.19%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $40.29
Upside: +16.65%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $5.91
Upside: +323.01%
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $1.27
Upside: +293.70%
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.96
Upside: +15,625.81%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.89
Upside: +2,590.58%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $1.09
Upside: +1,367.89%
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $8.35
Upside: +16,666.47%